4-aminobenzamidine has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwanaga, S; Miyata, T; Niho, Y; Nishimura, H; Okamura, T; Suehiro, K; Takeya, H | 1 |
| Albini, A; Bologna, M; D'Ascenzo, S; Festuccia, C; Giunciuglio, D; Guerra, F | 1 |
2 other study(ies) available for 4-aminobenzamidine and epidermal growth factor
| Article | Year |
|---|---|
Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
Topics: Adult; Asparagine; Benzamidines; Blood Coagulation Factors; Epidermal Growth Factor; Esterases; Factor IX; Factor VIIa; Factor X; Hemophilia B; Histidine; Humans; Hydrolysis; Kinetics; Male; Mutation; Peptide Mapping | 1993 |
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
Topics: Antibodies; Antineoplastic Agents; Benzamidines; Bombesin; Cell Division; Cell Membrane; Collagen; Collagenases; Culture Media, Conditioned; Drug Combinations; Enzyme Activation; Enzyme Induction; Epidermal Growth Factor; Extracellular Matrix; Fibrinolysin; Gastrin-Releasing Peptide; Humans; Laminin; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Prostatic Neoplasms; Proteoglycans; Serine Proteinase Inhibitors; Tissue Inhibitor of Metalloproteinase-1; Urokinase-Type Plasminogen Activator | 1998 |